chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting the day after dose 2 of COVID vaccination, left arm was numb and tingley.  Throbbing at night when sleeping on left side.  Vaccination did hurt when it was administered.  It felt much different at the time of vaccination; more pain, than the first COVID vaccination which was in the  other arm.  Saw medical provider after one month, since symptoms were not resolving.  6 day course of Prednisone was ordered and taken.  Symptoms are better, but not gone.  Has a follow up appointment with medical provider this week.
Side of my face doesn't work. I think I have bells palsey. Mouth is drooping. Can wink in one eye.
developed a worsening of their ITP; developed a worsening of their ITP; Rash; Headache; Chills; her platelet count was at 37,000; This is a spontaneous report from a contactable pharmacist. A 73-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 73 years old on 16Mar2021 at single dose for COVID-19 immunization. Medical history included medical diabetes mellitus with mild leukopenia without recurrent infection since 2005, Moderate thrombocytopenia. Concomitant medications were reported as none. The patient developed a worsening of her ITP, which was clarified as Idiopathic thrombocytopenic purpura on 23Mar2021. They thought the worsening of this condition was attributed to the vaccine. She was referring to the Pfizer BioNTech COVID-19 vaccine. The pharmacist made the comment the patient probably had her first dose around 23Feb2021, however, this cannot be confirmed. Pharmacist was unsure of the date when the patient had her first dose. The patient had reported she had a lot of side effects including rash, headache, chills on 23Mar2021. The last lab was done on 26Jan2021 and the patient's platelet count at that time was 88,000. She had a scheduled routine dental procedure and had a CBC done (in Mar2021) approximately 1 week after receiving the second dose of the COVID-19 vaccine. When the patient had labs done on 22Mar2021 (after receiving her second dose), her platelet count was at 37,000. The patient's platelet count stayed low like this after multiple labs were drawn. On 23Mar2021, her platelet count was at 44,000; On 29Mar2021, her platelet count was at 36,000; On 16Apr2021, her platelet count was at 26,000; On 22Apr2021, her platelet count was at 32,000. The patient was started on Dexamethasone 40mg orally for 4 days as treatment for the events. On 26Apr2021, her platelet count bounced back up to 64,000. On 03May2021, the patient's platelet count was at 125,000. The outcome of event platelet count low was resolving while outcome of other events were unknown.  Follow-up attempts are needed; information about lot/batch number has been requested.; Sender's Comments: Based on chronological connection to the vaccine causality between reported events and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to  Committees and Investigators, as appropriate.
Intense Diarrhea for 6 weeks. Different and worse than I have ever had in my life.
Information has been received from a reporter who mentioned that he heard of a boy in a family was vaccinated with one dose of MMR II on an unspecified date. One or two weeks later, the boy was diagnosed with autism. At the time of this report, the patient was not recovered. It was not specified if the patient sought medical attention or not. The reporter also heard another boy in the family was diagnosed with autism after receiving MMR II (WAES#0903USA03958). Upon internal review, autism was considered to be other important medical event. Follow-up information could not be obtained to verify the existence of an identifiable patient.
Induration, erythema with tenderness to touch upper arm, shoulder to elbow, along lateral aspect.
Red, swelling of deltoid, extending around upper arm approximately 6cm x 5cm red and swollen.
Cranky and fussy 7/21/15 but resolved 7/22/15.  Left thigh red and swollen and painful 7/21/15 and 7/22/15. Hib and DTap administered left thigh IM.
This case was reported by a consumer and described the occurrence of injection site rash in a female subject of unspecified age who was vaccinated with Fluarix for prophylaxis. A physician or other health care professional has not verified this report. On 18 October 2007, the subject received unspecified dose of Fluarix (unknown). In October 2007, on or after 18 October 2007 and on or before 20 October 2007, less than one week after vaccination with Fluarix, the subject experienced a rash in "the general area of the injection." At the time of reporting the outcome of the event was unspecified.
Injection on 08/01/19.  Mother brought patient to clinic on 08/02/19 for evaluation of vaccine reaction in left arm.  Assessment indicated left upper arm with erythema 3"X3", inflammation and was warm to the touch.  RN counseled comfort measures and to see MD if reaction worsens or does not improve.  Parent called and said she took patient on to see MD on 08/02/19 after leaving the health Department and MD did not prescribe medication, but informed of comfort measures and told parent that the patient should have allergy testing.  Parent said the allergy testing  has not been scheduled yet.  Parent said that it took 7 days for the swelling and redness to go away.  No further complaints or problems.
stroke; Heart attack; Facial paralysis; Herpes zoster; Postherpetic neuralgia; Cardiac issues; Balance problems; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 03-DEC-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) long-term prevention of shingles and zoster related conditions (prophylaxis). Subsequently, the patient was treated by a provider for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: herpes zoster, post-herpetic neuralgia, stroke (cerebrovascular accident), cardiac issues (cardiac disorder), heart attack (myocardial infarction), balance problems (balance disorder), and facial paralysis. The outcome of the events was not provided. Therefore, the causality for the events was related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the events cerebrovascular accident, myocardial infarction, and facial paralysis were determined to be medically significant.
A non-serious spontaneous case was received from a consumer involving flu and sore throat concerning a 40-year-old female.  No relevant medical or drug history information was reported.  The patient received FLUMIST on 06-Nov-2007.  The patient woke-up the following day with the flu and sore throat.  No outcome for the event was provided by the reporter.  The reporter provided no causality assessment for the events.  The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
Fever of 104 and 102 off and on for several days. Experienced chills, nausea, strange headache, lethargy, and runny nose as if I had COVID-19 again for many days. A few days after the second dose, the ringing in my ears doubled. (Ringing in my ears and hearing loss  developed after I got COVID in March 2020.) My smell and taste are even worse than before, i.e. a bowl of green beans forgotten on the counter overnight had no smell to me, but my son said they smelled horrible; a strong smell of exhaust was reported as coming to the car while I was driving, but I smelled nothing. I have no issues eating spicy food now, as it doesn?t register as hot. I only feel a slight tingly feeling around the edges of my tongue and mouth. As of today, the ringing in my ears is still at the elevated level and my smell and taste are not returned.
pt reports he has been sick since 8/20 and tested postive for covid a couple days ago, sob and o2 level was low
Extreme vertigo (dizziness) with nausea and vomiting, lasting 36 hours; sleepiness; lethargy; lack of hunger.
Hot at injection site; Red at injection site; Swollen at injection site; Itchy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FISH OIL, TURMERIC [CURCUMA LONGA RHIZOME], CUCURBITA PEPO SEED OIL, LYCOPENE, OENOTHERA BIENNIS OIL, SELENIUM, SERENOA REPENS, ZINC (SAW PALMETTO COMPLETE), CALCIUM, COLECALCIFEROL (VITAMIN D 3) and METHYLSULFONYLMETHANE (MSM COMPLETE) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This is a spontaneous report from a 59 year old male pt who received the 1st and 2nd dose of Lymerix on 3/23/99 and 4/27/99, respectively. Starting in June 1999, the pt experienced excruciating pain, tingly sensation, numbness and cramps (muscular) on the left side of his body. Additionally, he experienced chills, sweats, vertigo and fatigue. He has not driven a car in 6 weeks. He had one glass of wine and felt very drunk. He was seen by a physician and treated with ice packs, physical therapy, electro-stimulation, ultrasound therapy and ibuprofen. The most recent information received on 8/12/99, reports the condition of the pt as ongoing.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown gender and age. On an unknown date, the patients were vaccinated with a dose of PROQUAD (Merck) (lot # J011330, expiration date 13-MAR-2015, lot # K000711, expiration date 16-JUL-2015 and lot # reported as J014236 expiration date 07-MAY-2015) (dose not reported) that were improperly stored. The nurse stated that PROQUAD (Merck) had excursions of 7 F for 8 days and to 22 F for 5 days. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Sinus and head pressure with tightness in throat.  Resolved in 15-20 minutes.
Information has been received from a licensed practical nurse referring to unspecified patients of unknown age and gender. No pertinent medical history and concomitant medications were reported. On an unknown date, the patients were vaccinated with improperly stored ZOSTAVAX (dose, route, lot # and expiry date were not reported). No adverse effects were reported. Follow up information has been received from the licensed practical nurse on 09-JUN-2015. The nurse stated that the requested information for patient identifiers, lot number and expiration date and dates of vaccination were not readily available at time of contact. Follow-up information has been received from the licensed practical nurse on 24-JUN-2015. It was reported that 8 patients received improperly stored ZOSTAVAX (lot# K008880, expiry date 20-SEP-2015 (also reported as 09-SEP-2015)). Additional information is not expected as all the scheduled correspondence has been obtained. Product and narrative were updated. This is one of several reports from the same reporter.
Severe abdominal pain led me to ER, after blood work and CT scan i was diagnosed with pancreatitis.
6 days after rec FLUMIST, student c/o nausea and later on developed vomiting - dizziness as reported by his mother. Dx - Bell's palsy & now being worked up by neurology - (+) MRI for brain lesions again as reported to me by his mother. She said the doctor is r/o ADEM or MS. Has numbness Rt hand residual & still out of school to date, fatigue, & light-headed. Hospitalized - IV steroids per mother. Has been out of school since Nov 1 2012.
Post vax, the pt, while driving experienced shortness of breath, a rash across her chest and upper neck, and tachycardia. She did not stop breathing at any point. She went to the ER approximately 45 minutes after receiving vax and was treated with intravenous Decadron and Benadryl. The adverse events went away about one hour after receiving the emergency care.
Patient hospitalized fully vaccinated with the following diagnosis-  - Acute hypoxic respiratory failure secondary to COVID-19 - Acute COVID-19 pneumonia
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (patient had a definitive reaction to that type of vaccine), HYPOAESTHESIA ORAL (Numbness and tingling of her lips and tongue) and PARAESTHESIA ORAL (Numbness and tingling of her lips and tongue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.           The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  Treatment medication was not provided by the reporter.   Reporter did not allow further contact
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment medication  was not provided .
vision loss; herpes simplex in eye; vision problems; eye ulceration; eye pain; eye irritation; vomited; achy; fever; chills; nauseated; This case was reported by a consumer via call center representative and described the occurrence of loss of vision in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of influenza like illness (received 1st dose 3 months begore receiving the 2nd dose of Shingrix and experienced flu like symptoms, refer case US2019AMR142096).   On 12th July 2019, the patient received the 2nd dose of Shingrix. On 12th July 2019, less than a day after receiving Shingrix and an unknown time after starting acyclovir, the patient experienced pain. On 13th July 2019, the patient experienced vomiting, fever, chills and nausea. On 16th July 2019, the patient experienced loss of vision (serious criteria GSK medically significant), ophthalmic herpes simplex (serious criteria GSK medically significant), abnormal vision, eye ulcer, eye pain and eye irritation. The patient was treated with acyclovir and antivirals nos. On an unknown date, the outcome of the loss of vision, ophthalmic herpes simplex, abnormal vision, eye ulcer and eye pain were recovering/resolving and the outcome of the eye irritation was not recovered/not resolved and the outcome of the vomiting, pain, fever, chills and nausea were recovered/resolved.   The reporter considered the loss of vision, ophthalmic herpes simplex, abnormal vision, eye ulcer, eye pain and eye irritation to be related to Shingrix. It was unknown if the reporter considered the vomiting, pain, fever, chills and nausea to be related to Shingrix.  Additional details were provided as follows: After receiving the 2nd dose of Shingrix,in the night the patient felt achy. On the next day after receiving Shingrix, at about 5 in the morning the patient experienced fever,chills and felt nauseated. The patient had 101 degree F temperature.  The patient vomited and felt like aching all over that lasted for about two days. On 16th July 2019, the patient started experiencing vision problems. On 18th July 2019 and 22nd July 2019, she called her physician and was diagnosed her with herpes simplex in her left eye.  The physician said that the Shingrix vaccine caused the herpes simplex.  The patient's eye was painful, irritating and she lost vision on that eye.  The day before the date of reporting, the patient could not see how to put on her lipstick. Her ophthalmologist had been having her coming back every other day since two weeks. The patient also experienced some ulceration in her eye.  The patient was treated with Antivirus drops first and it had not helped her so on her fourth day of oral treatment she was treated with Acyclovir. The reporter consented to follow up. It was reported that the company could follow up with her if they really need to speak to her primary care physician as she had not shared any of the information with the physician till the time of reporting.
Patient fainted after the 2nd Shingrix injected.  Pt stated that he hadn't eaten yet today.   He was checked  blood pressure , pulse , blood sugar and EKG. by paramedic. After that , he felt better and left the pharmacy.
Pink papular rash to trunk with some areas that appeared more whelpy with petechial rash on bilateral arms that started on 1/1/20 and lasted 3-4 days with no other symptoms.
(may be unrelated)    Began having headaches on June 2, 2021, could feel but not see bumps on left back side of head...headache continued  sore throat beginning  6/5/2021; diagnosed with strep on  6/7/2021;  headache (radiating downward from bumps on head and upward from neck lymph nodes. Became severe, went to ER at 3:30 am on 6/10/2021; diagnosed with shingles at doctors office on 6/10/2021.   Head continued until about June 15.  Bumps still itchy today (July 9)
I was vaccinated and a month later I got shingles/suspected vaccination failure; I was vaccinated and a month later I got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 month after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I was vaccinated and a month later I got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I was vaccinated and a month later I got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 23-Jul-2023 The case was received from the patient via interactive digital media. The patient stated that did not trust vaccines too much. The patient was vaccinated and a month later he or she got shingles. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting.
Fever for 2 days, severe headache and sensativity to light for 10 days.
Experience heavy hot flashes 24/7 since vaccination.  Never before and have regular monthly cycle; can't be coincidental; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 25Mar2021 at 10:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to sulfa. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medication within two weeks of vaccination. On 28Mar2021, the patient experienced experience heavy hot flashes 24/7 since vaccination. The patient stated that never ever before and had regular monthly cycle and it could not be coincidental. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event hot flashes was not recovered at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 15Apr2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Patient came to get his first dose of Covid 19 moderna vaccine. He received 0.25 ml initially and the error was realized immediately and explained to the patient. He was then given 0.25ml on the same arm.
PATIENT PULLED AWAY DURING ADMINISTRATION OF DOSE, THE DOSE WAS NOT ADMINISTERED, HAD TO RE-ADMINISTER
Headaches every day . I went to the emergency and they did a cat scan results came back normal